Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Xylometazoline hydrochloride/ipratropium bromide
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Xylometazoline 70microg/Ipratropium brom 84microg/dose spy
1202020Q0AAAAAA
|
Xylometazoline hydrochloride/ipratropium bromide | Xylometazoline hydrochloride/ipratropium bromide | Ear, Nose and Oropharynx | 36 |
|
Otrivine Extra Dual Relief 0.5mg/ml / 0.6mg/ml nasal spray
1202020Q0BBAAAA
|
Otrivine (Xylometazoline hydrochloride/ipratropium bromide) | Xylometazoline hydrochloride/ipratropium bromide | Ear, Nose and Oropharynx | 18 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.